Protein Sciences Corp Revenue and Competitors

Meriden, CT USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Protein Sciences Corp's estimated annual revenue is currently $4.7M per year.(i)
  • Protein Sciences Corp's estimated revenue per employee is $77,500

Employee Data

  • Protein Sciences Corp has 60 Employees.(i)
  • Protein Sciences Corp grew their employee count by -12% last year.

Protein Sciences Corp's People

NameTitleEmail/Phone
1
Head Supply Chain and Flublok Influenza Vaccine Product LeadReveal Email/Phone
2
Head Vaccine Production OperationsReveal Email/Phone
3
Associate DirectorReveal Email/Phone
4
Senior Manager, Facilities and EngineeringReveal Email/Phone
5
Operations Systems Support ManagerReveal Email/Phone
6
Senior Manager /Upstream Process/ Process and Analytical Development DepartmentReveal Email/Phone
7
Manufacturing TechnicianReveal Email/Phone
8
group leader-general testingReveal Email/Phone
9
Building/Facility Support & IT SupportReveal Email/Phone
10
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M1-80%N/AN/A
#2
$4.3M288%N/AN/A
#3
$9.8M66-11%N/AN/A
#4
$1.4M9350%N/AN/A
#5
$16.6M107-23%N/AN/A
#6
$4.5M29-22%N/AN/A
#7
$1.7M1157%N/AN/A
#8
$2.3M15-6%N/AN/A
#9
$0.3M4-43%N/AN/A
#10
$4M260%N/AN/A
Add Company

What Is Protein Sciences Corp?

Protein Sciences Corporation (PSC) is a biopharmaceutical service company headquartered in Meriden, CT. PSC is the world leader in using the Baculovirus Expression Vector System (BEVS) on a commercial scale. The company is the partner of choice for pharmaceutical, biotechnology and genomics companies who seek the fastest, safest way to proceed from a gene target to a commercial vaccine, therapeutic, or screening molecule. We employ 40 people in process development, manufacturing, and management.

keywords:N/A

N/A

Total Funding

60

Number of Employees

$4.7M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Protein Sciences Corp News

2022-04-20 - Influenza Therapeutics Market Trends, Growth and Outlook ...

... Players – Chiron Corporation, Protein Sciences Corporation, Astrazeneca PLC, ... and thus important decisions for the growth of the company can be made.

2022-04-17 - Global Recombinant Vaccine Market to Showcase Vigorous ...

? Pfizer Inc. ? Sanofi S A. ? Protein Science Corporation ? GlaxoSmithKline Plc ? Novartis AG ? Bharat Biotech. Analysis of Cardan Shaft...

2022-04-17 - Pertussis Vaccine Market Size, Scope And Outlook ...

GlaxoSmithKline, Protein Sciences Corporation, Sanofi Pasteur, Novartis AG, Seqirus, Merck Sharp & Dohme Corp., and Astellas Pharma US, Inc. Market factors...

2007-08-23 - A biotech flu vaccine and the seduction of hype

(UPDATED: See below.) Vaccine developer Protein Sciences is all over the blogosphere today (see, for instance, items on Pharmalot and the WSJ health blog), thanks to a breathless Bloomberg piece on the little Meriden, Conn., biotech. According to Bloomberg reporter John Lauerman’s article, Prot ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.2M630%N/A
#2
$17.5M6734%N/A
#3
$20.4M695%N/A
#4
$11.3M78-2%N/A
#5
$26.7M9219%N/A